Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-20

Clinical Trial Update: A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)

View source ↗

Summary

A completed clinical trial evaluating OZURDEX for macular edema due to retinal vein occlusion, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Macular Edema, Retinal Vein Occlusion | Status: COMPLETED | Results posted: 2015-07-20